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Background: The cytoplasmic RIG-like receptors are responsible for the early detection of viruses and other
intracellular microbes by activating the innate immune response mediated by type I interferons (IFNs). RIG-I and
MDA5 detect virus-specific RNA motifs with short 5′-tri/diphosphorylated, blunt-end double-stranded RNA (dsRNA)
and >0.5–2 kb long dsRNA as canonical agonists, respectively. However, in vitro, they can bind to many RNA
species, while in cells there is an activation threshold. As SF2 helicase/ATPase family members, ATP hydrolysis is
dependent on co-operative RNA and ATP binding. Whereas simultaneous ATP and cognate RNA binding is
sufficient to activate RIG-I by releasing autoinhibition of the signaling domains, the physiological role of the ATPase
activity of RIG-I and MDA5 remains controversial.
Results: A cross-analysis of a rationally designed panel of RNA binding and ATPase mutants and truncated receptors,
using type I IFN promoter activation as readout, allows us to refine our understanding of the structure-function
relationships of RIG-I and MDA5. RNA activation of RIG-I depends on multiple critical RNA binding sites in its helicase
domain as confirmed by functional evidence using novel mutations. We found that RIG-I or MDA5 mutants with low
ATP hydrolysis activity exhibit constitutive activity but this was fully reverted when associated with mutations
preventing RNA binding to the helicase domain. We propose that the turnover kinetics of the ATPase domain enables
the discrimination of self/non-self RNA by both RIG-I and MDA5. Non-cognate, possibly self, RNA binding would lead to
fast ATP turnover and RNA disassociation and thus insufficient time for the caspase activation and recruitment domains
(CARDs) to promote downstream signaling, whereas tighter cognate RNA binding provides a longer time window for
downstream events to be engaged.
Conclusions: The exquisite fine-tuning of RIG-I and MDA5 RNA-dependent ATPase activity coupled to CARD release
allows a robust IFN response from a minor subset of non-self RNAs within a sea of cellular self RNAs. This avoids the
eventuality of deleterious autoimmunity effects as have been recently described to arise from natural gain-of-function
alleles of RIG-I and MDA5.
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The cytoplasmic RIG-I-like receptors (RLRs) provide
the first line of defense against virus infection [1, 2].
They recognize RNA species harboring 5′-triphosphate
or diphosphate ends and/or double-stranded features
(5′(p)ppdsRNA) [3–7] that are physiologically absent from
the cytosol (see [2] for review). The highly conserved RLR* Correspondence: denis.gerlier@inserm.fr
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LGP2. RIG-I and MDA5 detect virus infection and induce
an interferon (IFN) response, whereas LGP2 acts as a
regulator of RIG-I/MDA5-mediated activation (see [9, 10]
for review). RIG-I and MDA5 are composed of amino-
terminal tandem caspase activation and recruitment
domains (CARDs), a central helicase domain (hel) and a
C-terminal domain (CTD) (Fig. 1a). RIG-I or MDA5
CARDs, which are released upon cognate RNA binding,
mediate signal transduction by interacting with the CARD
of the membrane-bound mitochondrial antiviral signaling
(MAVS) adaptor [1, 11–14]. Indeed, RNA-bound RIG-I
[15] or MDA5 [16, 17] activate MAVS by promoting itsrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Refinement of RIG-I hel residues involved in hel2i-CARD2 interaction and RNA binding as assessed by RIG-I ability to activate the human
IFNβ-promoter in Huh7.5 cells. a Modular domain organization of RIG-I and location of amino acid substitution investigated in this study. hel
motifs involved in ATP binding or RNA binding are represented in blue and red, respectively, and in violet when involved in both of them.
b Functional investigation in Huh7.5 cells of hel2i residues contacting CARD2 F539 residue in RIG-I auto-repressed form and hel1/hel2i residues
involved in RNA binding without RNA (white columns), or stimulated with 5′pppdsRNA (grey columns) or poly(I:C) (black columns). Data (mean
+/− SD of three independent replicates, and the experiment was performed twice with similar results) were expressed in fold response of wt
RIG-I with poly(I:C) set up as 100 % activity. See Additional file 2 for protein expression levels of each construct analyzed by western blot. CARD:
caspase activation and recruitment domain; hel: helicase
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interactions. Multimerized MAVS acts as a central node
to recruit the kinases responsible for converting several la-
tent transactivators of cytokines including type I and III
IFN genes. The minimal RNA required to activate RIG-I
appears to be short 5′(p)ppdsRNA (10–20 nucleotides) lead-
ing initially to monomeric RNA-RIG-I complexes [18–21],
which can then multimerize by K63-linked polyubiquitin
chain-mediated interaction between the exposed CARDs
[22, 23]. In the case of MDA5, the transduction unit is a
multimer formed by the co-operative head-to-tail binding
of MDA5 monomers along a >0.5–2 kb dsRNA [16, 24, 25].
Sf2 helicase/ATPase family members, including RLRs,
are characterized by the coupling of nucleic acid and
ATP binding to a conformational switch which, in turn,
can trigger various downstream functions [12, 26]. Atthe same time, nucleic acid binding results in the allo-
steric activation of the ATPase. The sensitivity, duration
and (ir)reversibility of the switch is controlled by the
kinetics of ligand binding, the ATPase activity and even-
tual downstream effector interactions. In the case of
RIG-I and MDA5, evolution has fine-tuned these recep-
tors to exclusively detect and robustly respond to only
the tiny subset of foreign RNA species that harbor a par-
ticular molecular pattern amongst the sea of cellular self
RNA. Exactly how this is achieved is incompletely
understood and is the subject of this study. The central
sf2 hel domain comprises two recA-like domains (hel1
and hel2), with a helical insertion domain (hel2i) located
at the beginning of hel2 and a pincer domain in elbow,
the latter two being specific to the RLR family (Fig. 1a).
Structural and biochemical studies of RIG-I and MDA5
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served motifs Ia-Ic, IIa (hel1) and IV-V (hel2) in the
interaction with double-stranded RNA (dsRNA) and Q, I
(Walker 1), Ia, II (Walker B), III (hel1) and VI (hel2) in
the ATP binding and ATP hydrolysis [27–30]. According
to several structural and biochemical studies, ligand-free
RIG-I binds ATP poorly [28, 30]. The ATPase activity of
RIG-I and MDA5 is stimulated only in the presence of
bound dsRNA ligands [27, 28, 31], since the accurate po-
sitioning of key residues responsible for ATP hydrolysis
depends on conformational changes induced by RNA
binding [28, 30]. Furthermore, dsRNA has only re-
stricted access to RIG-I hel. Indeed, the multipartite
dsRNA binding site on hel (spread across hel1, hel2 and
hel2i) is kept in a flexible open conformation and is par-
tially hidden by the interaction of CARD2 with hel2i that
maintains RIG-I in an auto-repressed conformation [30].
Accordingly, the affinity of a CARD-deleted RIG-I con-
struct for 5′pppdsRNA increases by four-fold [32]. The
high affinity of RIG-I CTD for 5′(p)ppdsRNA (0.5 nM)
ensures its specific and efficient capture [5, 32–34]. As a
result, the dsRNA moiety can compete efficiently with
CARD2 for cis-binding to the hel domain. This results
in hel wrapping around the dsRNA in a closed conform-
ation that is stabilized by ATP binding [21, 30]. Indeed,
while the isolated RIG-I hel has no/low ATPase activity
even in the presence of RNA [28, 33], the hel-CTD frag-
ment exhibits strong ATPase activity [35] thanks to the
primary binding of the cognate RNA to the CTD [28, 33].
MDA5 shares with RIG-I a very similar structure of
the hel domain and CTD [16]. However, the recruitment
of its dsRNA agonist is unlikely to result from a primary
capture mediated by its CTD since MDA5 CTD only
has a very weak affinity to dsRNA (3 μM for 24-mer
dsRNA) [36, 37]. MDA5 hel has a slightly higher affinity
(1.5 μM for 24-mer dsRNA), whereas the affinity rises by
five-fold for full-length MDA5 (300 nM for 24-mer
dsRNA) [38]. Notably, the cooperative binding of MDA5
on longer dsRNA increases its affinity [25]. In cells,
MDA5 is activated mostly, if not only, by >2 kb long
viral dsRNA [6, 39], higher-order viral RNA structures
[40] or >0.5 kb of the synthetic dsRNA mimic poly(I:C)
[6]. The differently orientated CTD of MDA5 binds to
both the hel-bound dsRNA and hel2i [16], while hel2i of
one monomer binds to the pincer domain of the next
monomer according to a model of the head-to tail oligo-
mer [16]. The structure of the inactive state of MDA5 is
unknown.
The ATPase activity of RIG-I and MDA5 appears to have
a central physiological role since ATPase defective and
gain-of-function MDA5 and RIG-I alleles are associated
with either improved viral clearance [41] or autoimmune
diseases [42–45]. Furthermore, mutations disrupting the
ATPase activity of both RIG-I [27, 28, 46, 47] and MDA5[16, 27, 43, 48] can be associated with loss- or gain-of-
function. However, the precise underlying molecular
mechanisms remain puzzling. From experiments using a
RIG-I construct lacking CARDs (hel-CTD) interacting
with a short 5′pppdsRNA and ATP, a rapid on/off binding
cycle of 1–5 s duration was interpreted as reflecting ATP-
hydrolysis protein translocation along the dsRNA [49, 50].
Translocation of RIG-I, dependent on its ATPase activity,
has also been invoked to explain oligomerization of RIG-I
on longer 5′pppdsRNAs [51]. In the case of MDA5, ATP
hydrolysis has been shown to drive the dissociation of
MDA5 from dsRNA, thus controlling the efficiency of the
nucleation process leading to self-oligomerization on
dsRNA [25]. As a result, binding to short dsRNA is
kinetically unstable explaining why MDA5 is activated only
by >0.5–2 kb long dsRNA [52].
In this work, we further investigate the phenotype of
RIG-I and MDA5 molecules harboring substitutions dis-
rupting either the CARD2-hel2i interaction, the RNA
binding or the ATPase activity alone or in combination.
This allows us to demonstrate, for the first time, that all
ATPase-deficient RIG-I and MDA5 receptors that are
constitutively active rely on an intact RNA binding cap-
ability of their hel domain. Altogether our data led us to
propose a model of RIG-I and MDA5 activation from
auto-repressed forms in which the ATPase activity al-
lows both helicases to kinetically discriminate invading
non-self RNA from the cellular self RNA.
Results
Functional study of RIG-I CARD2
In the absence of an agonist RNA, RIG-I is in an inactive
auto-repressed state due to the binding of CARD2 to hel2i
that also hinders dsRNA binding to the hel [30]. Accord-
ingly, when overexpressed in Huh7.5 cells, which are in-
trinsically deficient in RIG-I, MDA5 and the response to
type I IFN (see Additional file 1 for details), wt RIG-I was
unable to activate the human IFNβ promoter (Fig. 1b).
Previously we reported that the mutation F539D leads to
constitutive RIG-I activity consistent with this hel2i resi-
due being key in mediating the sequestration of the
CARDs according to the crystal structure of full-length
duck RIG-I [30]. Here, again based on the crystal struc-
ture, we designed an additional three human RIG-I mu-
tants, this time on the CARD2 side of the CARD-hel2i
interface. All three mutants, RIG-I_CARD[P112A,M149A],
RIG-I_CARD[P112A,T116K,M149A], RIG-I_CARD[P112A,
M149A,L185E], were found to be inactive despite being
well-expressed (Fig. 1b and Additional file 2). Since we ex-
pected these mutants would mirror the F539D mutation
and also exhibit constitutive activity, their loss-of-function
phenotype suggests that the CARDs bearing these
combined mutations are unable to transduce the acti-
vation signal to MAVS. The single RIG-I_CARD[P112A]
Louber et al. BMC Biology  (2015) 13:54 Page 4 of 16substitution exhibited a 50 % reduction in its ability to ac-
tivate the IFNβ promoter upon RNA stimulation after
poly(I:C) or a 61-mer-5′pppdsRNA stimulation. This is in
contrast to the previously reported loss of constitutive ac-
tivity of isolated RIG-I CARDs carrying the same P112A
mutation [22]. Interestingly, when the P112A constructs
were expressed in 293T cells, which is endowed with a
minimal functional RLR and IFN response, they exhibited
a significantly higher constitutive activity over that ob-
served with wt RIG-I (see Additional file 3). This suggests
that despite being inherently less efficient (P112A) and un-
able to be activated by cognate RNA, [P112A,M149A],
those mutants could directly or indirectly stimulate an en-
dogenous RLR response, the underlying mechanisms of
which remain unclear.
Further insights in RNA binding sites of RIG-I hel domain
Within the helicase IIa motif, Q380 is a phosphate bind-
ing site for the 5′ strand of dsRNA [30]. The Q380P
substitution was introduced into the hel1 subdomain of
wt RIG-I. RIG-I Q380P did not elicit signal transduction
upon stimulation with poly(I:C) or 5′pppdsRNA (Fig. 1b).
The combined K508A, Q511A, V514A and K518A sub-
stitutions in the hel2i subdomain interface with the
dsRNA ligand could also abolish the recognition of
poly(I:C) and 5′pppdsRNA in Huh7.5 cells (Fig. 1b), a
phenotype that was also observed in 293T cells (Additional
file 3). The comparison of RIG-I hel-CTD/RNA (PDB ID
4AY2) and MDA5 hel-CTD/RNA (PDB ID 4GL2) [16]
structures suggested to us that hel2 residues 666–671 of
hRIG-I, a partially ordered loop in most crystal structures,
may contact the 5′ppp end of dsRNA. Additional file 4
shows that this is not the case since substitution of this 6
aa long loop by the corresponding 7 aa long loop from
MDA5 or LGP2, or by an unrelated sequence SGSGSS,
hardly affected the stimulation by 5′pppdsRNA or
poly(I:C).
The constitutively active RIG-I E373Q ATPase mutant
relies on both hel and CTD RNA binding sites
To evaluate the role of the ATPase activity of RIG-I in
its ability to transduce a signal in cellula, the functional
impact of substitutions in the helicase motifs I, II and III
was studied (Fig. 1a). The K270A (motif I) mutant,
which abrogates ATP binding [47], exhibited a signifi-
cant residual response to the stimulation by 5′pppdsRNA
or poly(I:C). This response was abrogated when K270A
was associated with mutations previously reported to reduce
the RNA binding capability of either the hel or the CTD do-
mains, that is, by introducing the hel T697A/E702A
substitutions [27] (called here hel°), or the CTD K888A/
K907A substitutions [34] (called here CTD°) (Fig. 2). In con-
trast to K270A, we found that the E373Q (motif II) mutant
displayed a significant and reproducible constitutive activity(Fig. 2) and could be further activated by both dsRNAs.
When associated to hel°, E373Q became inactive as does wt
RIG-I. When associated to CTD°, E373Q exhibited a re-
sponse profile similar to that of its wt counterpart, namely,
no constitutive activity and significantly reduced response to
both dsRNAs (Fig. 2). The T409S/S411A (TS/AA) ATPase
mutation (motif III) resulted in a limited response profile
with no constitutive activity and a low response to both
RNAs of similar magnitude to those observed with wt-CTD
° and E373Q-CTD°. When TS/AA was combined with hel°
the response to either dsRNA disappeared (Fig. 2). Import-
antly, the phenotype of E373Q was distinct from that of the
constitutively active F539D mutant [30]. Indeed, F539D
remained active even when associated with either CTD° or
hel° indicating a destabilization of the auto-repressed state
of RIG-I. This destabilization, however, is not complete (the
CARDs are not completely free) since a cognate RNA in-
duced an additional signal to the F539D constitutive activity
that was annihilated when this substitution was associated
with either CTD° or hel° RNA binding mutants. Similar re-
sults were obtained when working with 293T as host cells
(Additional file 3).
The constitutive activity of MDA5 ATPase mutants relies
on an intact hel RNA binding site
As quoted above, the ectopic expression of hMDA5 (see
Fig. 3a for domain organization) resulted in a significant
activation of the human IFNβ promoter (Fig. 3b), and
the response could be significantly enhanced by stimula-
tion with Phi6 dsRNA or poly(I:C) (Fig. 3b), a finding
also illustrated in Additional file 5A. All the individual
K335A, E444Q, T488A/S490A (TS/AA) and G821S sub-
stitutions located in the ATPase resulted in a strong
constitutive activity far exceeding the response of wt
MDA5 to dsRNA stimulation (Fig. 3b), with E444Q dis-
playing the highest and G821S the lowest activity, re-
spectively (see also Fig. 3c). None of the ATPase
mutants exhibited an additional response to Phi6 dsRNA
or poly(I:C). The constitutive activity of these mutants
was maintained when associated to CTD° (H927A [37]),
showing that an intact RNA binding site on the CTD
was not required. In contrast, altering the RNA binding
site on MDA5 hel (R728A, hel° [16]) reduced the activity
to the background level observed with wt MDA5. Al-
though partially obscured by the presence of endogenous
RLR and response to interferon, similar results were ob-
tained with wt and E444Q mutant in 293T host cells
(Additional file 3).
The constitutive activity of MDA5 ATPase mutants is
disrupted by V protein and relies on MDA5 self-
oligomerization
Paramyxovirus V protein binds tightly to the hel2 do-







































Fig. 2 Interplay between the ATPase activity and RNA binding sites of RIG-I to elicit a signal. The ability of wt, hel2i F539D, ATPase E373Q, K270A
and T409A/S411A (TS/AA) mutants RIG-I harboring or not mutations that loosen the RNA binding sites on the hel (T697A/E702A, hel°) or CTD
(K888A/K907A, CTD°) domain were tested for their ability to activate the human IFNβ promoter. Note lower signalling ability of the F539D-CTD°
mutant correlates with its lower expression as determined by western blot (see Additional file 2). The activity of F539D and E373Q was constitutive at
P <0.0025 and P <0.01, respectively. All ATPase variants with intact hel and CTD domains significantly responded to both 5′pppdsRNA and poly(I:C) with
the possible exception of TS/AA variant stimulated by the 5′pppdsRNA (P <0.05 to <0.005 range, in comparison with the signal without exogenous
dsRNA). The wt, K270A, E373Q and TS/AA CTD° variants lost their response to 5′pppdsRNA (P <0.025 to <0.01 range in comparison with intact CTD
counterparts), and also to the poly(I:C) in the case of K270A mutant (P <0.01). E373Q-hel° was inactive (P <0.001 versus 373Q) as were all hel° constructs
(P <0.05 to <0.025 range versus counterparts with intact hel domain). The constitutive activity of the F539D mutant (P <0.0025 versus wt) remained
unaffected when associated to either CTD° or hel° if the lower protein expression level of F539D-CTD° construct is taken into account. The significant
response of F539D construct to both dsRNAs (P <0.05 and P <0.01 versus no RNA) was abolished if associated with hel° or CTD°. Note the log scale
display of the IFNβ activation because values were within a large range. See Additional file 2 for protein expression levels of each construct analyzed
by western blot. CTD: C-terminal domain; hel: helicase
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in Additional file 5B), and inhibiting MDA5 function
[54]. Accordingly, all MDA5 ATPase mutants lost most
of their constitutive activity in the presence of measles
virus V (MeV V). Similar results were obtained with a
C-terminally truncated V protein (MeV V-STOP) that
lacks the RIWY motif that has been described to inhibit
positive regulation of MDA5 signal transduction by the
PP1α/γ phosphatases [55] (Fig. 3c). In fact, MeV V-
STOP exhibited the strongest inhibitory effect on both
the constitutive activity of ATPase mutants and on
dsRNA-induced activation of wt MDA5. As a control, V-
E235A, which is deficient in binding to MDA5 [53] (as
detailed in Additional file 5), showed a minimal inhibi-
tory effect, as expected.
When the E444Q mutation was combined with I841K/
E842R (IE/KR) substitutions that disrupt dsRNA driven
MDA5 self-assembly [16], the constitutive activity was
drastically reduced indicating the requirement of an in-
tact MDA5 self-oligomerization process. However, both
wt and E444Q MDA5 with IE/KR substitution retained a
small but significant response to the stimulation with
Phi6 and poly(I:C) (Fig. 3d). The use of 293T cellsinstead of Huh7.5 cells resulted in similar phenotype
ranking (Additional file 3).
DECH/DQCH mutation in the ATPase results in reduced
kinetics of ATP hydrolysis
We further studied the DECH to DQCH mutants, since
the isolated E/Q mutation in the DEAD motif of another
helicase/ATPase, Vasa, exhibited only very slow ATP hy-
drolysis and product release, allowing trapping of bound
RNA [56]. Indeed both purified duck RIG-I (Fig. 4a) and
chicken MDA5 (Fig. 4b) E/Q mutant hydrolyzed ATP
much slower than their wild-type counterparts. More-
over, this decrease in ATPase efficiency was not accom-
panied by a measurable change in the affinity for dsRNA
as determined by electrophoretic mobility shift assay
(EMSA) (Fig. 4d,e). Furthermore, deleting the CARDs
from MDA5-E444Q resulted in a ten-fold increase in
the hydrolysis slope (MDA5 hel-CTD-E444Q, Fig. 4c).
This suggests a more stable access of the dsRNA in the
absence of the CARDs since dsRNA/hel-CTD complex
formation was quantitatively indistinguishable in EMSA
(Fig. 4f ). Interestingly, EMSA of MDA5 hel-CTD con-
structs showed three species of shifted bands that might
Fig. 3 Interplay between the ATPase activity and RNA binding sites of MDA5 to elicit a signal. a Schematic domain organization of human MDA5.
b Ability of MDA5 ATPase mutants to activate the IFNβ promoter in Huh7.5 cells. Expression of MDA5 activates the IFN promoter (P <0.0005). Compared to
wt, ATPase variants with intact RNA binding sites exhibit a constitutive activity (P <0.05 to <0.0025). In contrast, the wt-CTD° and wt-hel° constructs, which
have an altered RNA binding site due to R728A and H927A substitution, respectively, do not respond to both dsRNAs. The association of CTD° reduces the
constitutive activity of only G821S (P <0.0025), with G821S-CTD° exhibiting a residual response to both dsRNAs (Phi6, P <0.025, poly(I:C), P <0.0025). Hel° in-
hibits both constitutive and RNA-dependent activities (P <0.05 to <0.005) down to the background activation level of IFNβ promoter observed with wt
MDA5 (P <0.01 to <0.0025). c Inhibition of constitutive activity of every ATPase mutant by MeV V (P <0.025 to <0.0005 versus MeV F control) and MeV
V-STOP (P <0.01 to <0.0005), but not by MeV V-E235A (P <0.05 to <0.0005). MeV V-STOP had higher inhibitory effect than MeV V (P <0.05 to <0.0005). In
the presence of poly(I:C), the profile of inhibition of wt and E444Q MDA5 activity by MeV V and V-STOP was similar (MeV V or V-STOP versus F, P <0.05 to
<0.005 and V-E235A versus V or V-STOP, P <0.05 to <0.0005). In panel (C), E444Q displayed the strongest constitutive activity (P <0.025 to <0.005), and
K335A, TS/AA and G821S shared a similar constitutive activity. d IE/KR substitution alone significantly reduced observed responses of all constructs (P <0.05
to <0.0005 versus wt). As observed in panel (B) the introduction of hel° abolished both the response to dsRNA and constitutive activity of MDA5 variants
(P <0.01 to <0.0005). Upon stimulation with Phi6 and poly(I:C), both wt and E444Q MDA5 with IE/KR substitution retained a significant activity (P <0.0025,
P <0.01, P <0.0025 and P <0.0005, respectively), with a significantly higher response to poly(I:C) than to Phi6 (P <0.0125 and P <0.0025). See Additional file 2
for protein expression levels of each construct analyzed by western blot. CTD: C-terminal domain; hel: helicase; MeV: measles virus
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Fig. 4 DECH/DQCH mutation in ATPase domain of a dRIG-I and b chMDA5 results in much slower ATP hydrolysis ability without affecting RNA
binding and ablation of CARDs from chMDA5 DECH/DQCH mutant (hel-CTD construct), enhancing the c ATP hydrolysis rate. The hydrolysis of
ATP by all three DECH/DQCH mutants increased linearly over 30 minutes as shown by equations and correlation analysis. ATP hydrolysis assay
was performed by incubating a 0.5 μM RIG-I, 2 μM 12dsRNA, and b, c 2 mM ATP or 8 μM MDA5, 32 μM 24dsRNA, 2 mM ATP. d, e, f Representative
EMSA showing the ability of wt (DECH) and DQCH proteins to bind to dsRNA. Each lane contains 40 ng cy3 labelled 12dsRNA (EMSA of duck RIG-I),
24dsRNA (EMSA of chicken MDA5), and increasing the concentration of d dRIG-I or e chMDA5 or f chMDA5 hel-CTD concentrations (0.25–8 μM). CARD:
caspase activation and recruitment domain; CTD: C-terminal domain; EMSA: electrophoretic mobility shift assay; hel: helicase
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mers, such supershifting being not observed with full-
length MDA5 (Fig. 4, compare e and f).
In the absence of the CTD, RIG-I remains auto-repressed
due to the pincer, while MDA5 remains inactive even
when the pincer and the last β-strand of its hel domain
are deleted
As reported previously [46], RIG-I with a C-terminal
truncation in the pincer-CTD linker to remove the CTD
domain (RIG-I 1–797, denoted CARD-hel) is unable to
be activated by poly(I:C) (Fig. 5 and Additional file 6).
When a similar truncation is made to hMDA5, the
resulting CARD-hel construct (aa 1–895) displayed only
the background activity observed with the ectopic ex-
pression of full-length MDA5, and was not activated bypoly(I:C) (Fig. 5a and Additional file 6). This suggests
that, as for RIG-I, MDA5 CARD-hel is maintained in an
auto-repressed form. Correlatively, the CARD-hel with
E/Q mutation from both RIG-I and MDA5 do not ex-
hibit any constitutive activity as their wild-type counter-
parts and in marked contrast with their full-length
counterparts (compare Figs. 3 and 5).
From the RIG-I and MDA5 crystal structures, the pincer
domain likely contributes to maintaining the architecture
of the hel domain in addition to its role in allosteric
stabilization of the ATPase core [57]. We thus questioned
its role in maintaining RIG-I and MDA5 in their auto-
repressed and inactive forms, respectively. Indeed, further
truncation of RIG-I CARD-hel from the pincer domain
alone (RIG-I 1–744, denoted Δ[pincer-CTD]), or together


























Fig. 5 CTD deletion of both RIG-I and MDA5 locked them in an
auto-repressed form which is alleviated by deletion of the pincer
domain in the case of RIG-I. a CARD-hel, RIG-I 1–797 and MDA5
1–895, and CARD-hel° constructs and their DQCH mutant display
only background activity similar to their full-length (wt) counterparts
and do not respond to poly(I:C). Note by comparison the significant
albeit reduced response to poly(I:C) of full-length RIG-I and MDA5
with CTD° unable to bind RNA (P <0.025 for both) when compared
to CTD° without poly(I:C), and P <0.0025 and P <0.0125 when
compared to wt constructs + poly(I:C), respectively, consistently with
data shown in Figs. 2 and 3. b Further deletion of the pincer domain
alone, RIG-I 1–744 quoted Δ[pincer-CTD], or together with deletion
of the last hel2 βsheet, RIG-I 1–734 quoted Δ[β13pincer-CTD],
results in constitutive activity of RIG-I (P <0.025 and below). In contrast,
their MDA5 counterparts MDA5 1–836 quoted Δ[pincer-CTD] and
MDA5 1–824 quoted Δ[β13pincer-CTD], shows no enhancement over
the background activity exhibited by MDA5 hel and hel° constructs
(P >0.05 and above). Free CARDs from both RIG-I (aa 1–228) and MDA5
(aa 1–294) are constitutively active (P <0.01 for both). Note that the
lower basal activity (*) of MDA5 Δ[pincer-CTD] construct is associated
with a lower expression level. CARD: caspase activation and recruitment
domain; CTD: C-terminal domain; hel: helicase
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tive activity albeit lower than that observed with the
CARDs alone (Fig. 5b). Surprisingly, similarly truncated
MDA5 constructs (aa 1–836 and aa 1–824) did not exhibit
activity above the basal background observed with full-
length MDA5, suggesting that the MDA5 pincer is not re-
quired in maintaining its inactive state. Isolated CARDs
from both RIG-I (aa 1–228) and MDA5 (aa 1–294) exhib-
ited, as expected, a constitutive activity (see also Additional
file 6 for other CARD constructs). These particular pheno-
types of RIG-I and MDA5 truncated constructs were also
observed in 293T cells (Additional file 3).Discussion
CARD sequestering by the hel domain as a common
feature for auto-repressed forms of RIG-I and MDA5
Despite intensive investigations, the mechanism of RIG-I
and MDA5 activation remains only partly understood.
The structure of ligand-free full-length and CARD-hel
RIG-I reveals an auto-repressed state with the CARD2
domain bound to the hel2i subdomain [30]. This inter-
action is further supported by the 50 μM affinity mea-
sured between the isolated CARD and hel domains [54].
This binding involves a hydrophobic network between
CARD2 P112, T116, M149 and L185, and hel2i F539
[30]. That this network drives the exposure of CARDs
and signal transduction is supported by the constitutive
phenotype of the F539D mutant even when associated
to the hel° or CTD° domain that are deficient in RNA
binding. The converse mutation of multiple CARD2 res-
idues that include M149 results in inactive RIG-I. M149
is located at the RIG-I CARD2/MAVS CARD interface
in the crystal structure of chimeric constructs [15], sug-
gesting that these mutants are inactive because they can-
not interact correctly with MAVS despite the CARDs
being released. This further supports, as we previously
suggested [30], that the CARD2 surface involved in the
recruitment of the signaling effectors is inaccessible in
the auto-repressed form of RIG-I, thus ensuring a strict
dichotomy between the ‘off ’ and ‘on’ activation state.
The CARD-hel domain is also auto-repressed showing
that the CTD is not required to maintain this state [30, 57]
(Fig. 5). On the contrary, the pincer domain is required to
maintain the auto-repressed state since upon its deletion,
CARD-hel become constitutively active, a finding that was
initially misinterpreted as indicative of CTD bearing a re-
pressor activity when testing the truncated RIG-I 1–734
(denoted Δ[β13-pincer-CTD]) [58].
In the case of MDA5, the facts that the CARD-hel
construct has a minimal level of constitutive activity
identical to that observed with full-length MDA5 and
that isolated CARDs are constitutively active [48] (Fig. 5
and details in Additional file 6) suggest that, in the rest-
ing state, MDA5 might also adopt an auto-repressed
state with the CARDs sequestered. Contrary to RIG-I,
the pincer domain does not appear to be involved in
maintaining this state. The ten-fold higher ATPase activ-
ity of MDA5-E444Q construct lacking the CARDs (com-
pare Fig. 4b and c) further suggests a competition
between dsRNA and CARDs for binding to the hel do-
main as it is the case for RIG-I. Likewise, the formation
of MDA5 oligomers suggested by supershifted bands in
the absence of CARDs (Fig. 4f ) compared to full-length
(Fig. 4e) argues that the CARDs may mask MDA5 self-
oligomerization sites. How MDA5 hel domain maintains
the CARDs in an inactive state is unknown but it ap-
pears to be less robust than for RIG-I, since biochemical
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bacterially expressed MDA5 CARDs and hel [38] or con-
tact surfaces that would be protected from deuterium
exchange [21]. Interestingly, the CARD2 surface in-
volved in recruiting the signaling effectors has a similar
location in RIG-I and MDA5 [22]. Importantly, the CTD
of both RIG-I and MDA5 appears to be essential in alle-
viating their auto-repressed/inactive forms since CARD-
hel constructs lacking the CTD lose their ability to be
activated by their cognate RNA.
Multiplicity of critical RNA binding sites of RIG-I hel
domain
In accordance with the canonical functions of the vari-
ous conserved helicase motifs [59] and the footprint
spanning 9–10 bp of dsRNA according to crystal struc-
tures [30], the SF2 helicase family conserved motifs pri-
marily involved in RNA binding are motifs Ia [29, 30], Ib
and Ic [28, 29], IIa [28–30], IV [30] and V [27]. Conse-
quently, critical residues for dsRNA recognition in cel-
lula appear widely distributed all over the hel domain as
functionally demonstrated with Q380 (IIa, this work),
Q507, K508, Q511, V514 and K518 (hel2i, α-helix 12,
this work), the participation of which is cumulative as
shown by the partial reduction of dsRNA recognition ex-
hibited by individual substitution of Q511A [29] or com-
bination of only some of them (this work), and T697/
D702 (V/Va) [27]. A series of crystal structures shows
the hel2i residues K508 and Q511 contacting several dif-
ferent base pairs along the dsRNA, which has been inter-
preted to reflect a sequential scanning movement of the
hel2i domain along a 10-mer dsRNA [19]. Overall, the
successful recognition of 5′pppdsRNA bound to RIG-I
CTD by the hel domain relies on a network of critical
residues ideally arranged to support a reciprocal allo-
steric control with ATP fixation and hydrolysis.
Model of ATPase-mediated discrimination of non-self RNA
by RIG-I
The key result from our work is the demonstration that
the constitutive activity of RIG-I ATPase mutants is
dependent on an intact RNA binding ability. This sug-
gests that this constitutive activity is stimulated by the
binding of cell-intrinsic RNAs and that the ATPase ac-
tivity is required to avoid self-activation of RIG-I. From
the available information including our present work, we
propose the following model of RIG-I recognition of a
cognate RNA leading to signal transduction (Fig. 6a). In
the resting state, RIG-I is kept in an auto-repressed form
with CARD2 binding to hel2i that impedes direct access
of RNA to the hel domain, a state apparently stabilized
by the pincer domain. Upon viral infection, RIG-I CTD
selectively traps non-self 5′pppdsRNA ectopically present
in the cytosol with high affinity (nM range [31, 32, 60])(Fig. 6a, step 1). This favors the cis-binding of the
dsRNA moiety to the hel domain favoring the co-
operative binding of ATP [28, 57] (Fig. 6a, step 2). ATP
fixation together with RNA binding stabilize the closed
conformation of RIG-I (Fig. 6a, step 3a). RIG-I K270A,
which binds weakly to ATP, is poorly active because
dsRNA cannot bind stably to RIG-I hel as shown by the
enhanced recycling of bound cognate RNA [61, 62].
Thus, both RNA and ATP binding to hel are needed for
efficient eviction of CARD2 from hel2i and the constitu-
tion of the ATP-locked-RIG-I/5′pppdsRNA complex that
can act as an active transduction unit (Fig. 6a, step 4a).
At the same time, the ATPase is activated with ATP hy-
drolysis promoting eviction of the bound RNA from the
hel domain as shown by the ATP hydrolysis-dependent
recycling of cognate RNA [61] (Fig. 6a, step 3b). How-
ever, because the 5′pppdsRNA is firmly maintained in
close proximity by remaining bound to the CTD (with
notably the 5′ppp moiety enhancing the lifetime of this
complex [34]), it can immediately rebind in cis to hel to
resume another cycle of ATPase activity (Fig. 6a, step 3a).
This multiple repetition of RNA/hel association/dis-
sociation powered by the ATPase motor maintains suf-
ficient CARD exposure (Fig. 6a, rolling steps 3a/4a/3b)
to ensure a sustained number of activated RIG-I mole-
cules per time unit above the critical threshold required
for commitment, that is, ubiquitination and inter-
action/activation with/of MAVS and switch-on of the
IFNβ promoter (Fig. 6a, rolling step 4a). Because the
CTD (even with a weaker RNA binding activity as in
the CTD° constructs) is strictly required and accom-
modates itself into a pocket in hel2i when hel is oc-
cupied by the RNA, one cannot exclude a possible
contribution of the CTD to hel2i interaction in the
full eviction of the CARDs from hel2i, as recently
suggested [21].
In this model, any serendipitous binding of a non-
cognate, self RNA (for example, a stem-loop structure)
directly to RIG-I hel (Fig. 6b, step 2b) would be rapidly
counteracted by RNA dissociation from RIG-I by the
ATPase motor (Fig. 6b, step 3b) in an irreversible manner,
because non-cognate, self RNA would lack the strong tri-
phosphate anchoring to the CTD. Indeed, artificial non-
optimal RNA ligands associate with increased ATPase ac-
tivity, increased recycling of bound RNA and inability to
activate the IFN response in cells [61]. Consequently, the
CARDs would be either never fully exposed, or only too
transiently, to result in enough simultaneous activated
RIG-I required for downstream oligomerization with ubi-
quitin chains and MAVS (Fig. 6b, step 4b). In the case of
RIG-I-E373Q, serendipitous binding of self RNA (Fig. 6c,
step 2b) coupled with slow ATP hydrolysis and product
release delays the eviction of the RNA from hel, and con-
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Fig. 6 Model of ATPase-mediated discrimination of non-self RNA by RIG-I. a Activation model of wt RIG-I. In resting state, RIG-I is in an auto-repressed
form with CARD2 binding to hel2i, which prevents RNA binding to the hel domain. Upon a viral infection, RIG-I CTD selectively catches non-self
5′pppdsRNA (1). This favors the cis-binding of 5′pppdsRNA to the hel domain that allows/enhances ATP binding by allosteric effect (2). ATP binding
promotes RIG-I folding into closed state with release of CARD2 away from hel2i and exposure of the CARDs (3a). ATP hydrolysis causes ADP+Pi release,
hel opening, allosteric weakening of the RNA to hel interaction and CARD resequestration (3b). Because remaining bound to CTD by its 5′pppdsRNA
end, RNA rebinding to hel in cis is favored (3a), which resumes another cycle of ATP fixation, CARD release and ATP hydrolysis (3a and 3b). Rapid
repetition of RNA/hel association/dissociation powered by the ATPase motor with on/off cycling of CARD exposure (4a) ensures a sustained level of
activated RIG-I molecules per time unit above the critical threshold required for effective signalling. b A fortuitous binding of self RNA to hel (2b)
induces ATP fixation, closed conformation and ATP hydrolysis that irreversibly evicts the RNA from hel, because it lacks CTD anchoring. Consequently,
the CARDs are exposed too transiently, if ever, to reach the threshold number of transduction units per time unit required for signalling (4b). c Model
of the constitutive activity of RIG-I-E373Q. Surrounding (self) RNA serendipitously binds to hel (2b), allows ATP binding with eviction of CARD2 from
hel2i (3a). The slow ATP hydrolysis refrains the eviction of the RNA from the hel and CARD2 resequestering (step 3b is very slow). Consequently, a
sustained level of activated RIG-I-E373Q molecules with their CARDs exposed accumulate above the threshold level required for IFNβ promoter
activation (4c). CARD: caspase activation and recruitment domain; CTD: C-terminal domain; hel: helicase
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of activated RIG-I-E373Q molecules per time unit (be-
cause of the increased half-life of the active RIG-I con-
formation) to give rise to signalling (Fig. 6c, step 4c).
Interestingly, the alternative E373A substitution that is a
natural constitutive variant associated with atypical
Singleton-Merten syndrome [42] also displays a similar
slow rate of ATP hydrolysis (Additional file 7). By analogy
with the reduced RNA binding affinity to the yeast Has1p
helicase with T/A or S/A substitution in motif III hy-
droxyls (SAT) [63], the reason why the TS/AA RIG-I mu-
tant is inactive might be the reduced ability of hel to bind
any RNA including self RNA. Thus, the ability of wt RIG-I
to escape illegitimate activation by self RNA is kinetically
controlled by fast ATP turnover that quickly dissociates
non-cognate RNA from the hel, thus allowing reestablish-
ment of the auto-repressed state.
Model of ATPase-mediated discrimination of non-self RNA
by MDA5
In the resting state, our functional data support that
MDA5 is in an inactive (possibly auto-repressed) form
since MDA5 CARDs are constitutively active but CARDs-
hel are not. As suggested by the higher ATPase activity
resulting from the deletion of the CARDs from the
MDA5-E444Q mutant, and by analogy with RIG-I, MDA5
CARDs may bind to hel to compete with RNA. As for
RIG-I, the CTD is strictly required to alleviate the inactive
conformation very likely because, according to the crystal
structure of MDA5 [Hel-CTD + dsRNA] complex, MDA5
CTD should tightly contact hel2i when hel is occupied by
RNA, this presumably freeing the CARDs for signal trans-
duction. All together our data and previously published
work suggest the following model for MDA5 discrimin-
ation of self from non-self RNA. A viral dsRNA binds to
MDA5 hel (Fig. 7a, step 1), which allows CTD binding to
hel2i that secures RNA binding to hel by inducing the re-
lease of the CARDs (Fig. 7a, step 2). This also results in a
conformational change that exposes the self-oligomerizationsurface, which engages the hel2i of one monomer to the
pincer domain of the next MDA5 monomer. This nucle-
ates an assembly cascade of other MDA5 molecules on
the same dsRNA (Fig. 7a, step 3) and formation of a multi-
valent CARD platform endowed with efficient signalling
power (Fig. 7a, step 4). At the same time, dsRNA binding
to hel favors the allosteric binding of ATP to the ATPase
motor. This results in ATP hydrolysis (Fig. 7a, step 5)
which releases the dsRNA from the hel domain of MDA5.
Consequently, disassembly of the oligomer is promoted
with each MDA5 monomer returning back to either re-
assemble (Fig. 7a, step 5) or to the inactive state (Fig. 7a,
step 6). The key observation we report here of the depend-
ence of the constitutive activity of MDA5 ATPase mutants
on an intact RNA binding ability demonstrates that seren-
dipitous binding of wt MDA5 to cellular (self ) dsRNA
most likely occurs (Fig. 7b). In this case, the resulting
complex is too short-lived to recruit another MDA5 mol-
ecule before self RNA is expelled by the ATPase motor
(that is, step 3 is pre-empted by step 5, Fig. 7b, step 4b).
What makes the difference between scenario A (non-self
RNA) and B (self RNA) is mainly the length of the RNA
duplex: in the physiological context of a low endogenous
expression of MDA5, the probability of the MDA5 nucle-
ation process, namely recruitment of a second MDA5
molecule attracted by one bound MDA5 with exposed
oligomerization surface, is predicted to increase with
dsRNA length because both MDA5 rebinding to the adja-
cent dsRNA sequence and the frequency of recruitment of
MDA5 monomers along the same RNA is favored by
dsRNA lengthening. In other words, in the case of MDA5,
the dsRNA length would statistically act as a surrogate
RNA anchor, a role played by the CTD of RIG-I. Another
difference is the ATP binding being dispensable for
MDA5 signalling. Instead, it is MDA5 self-oligomerization
that further stabilize MDA5 binding to dsRNA, thus creat-
ing a multimeric signalling platform. As for RIG-I, the
ATPase of MDA5 is kinetically required for its
desensitization, and reducing the rate of ATP hydrolysis
Fig. 7 (See legend on next page.)
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Fig. 7 Model of ATPase-mediated discrimination of non-self RNA by MDA5. a Activation model of wt MDA5. In resting state, MDA5 is in an auto-
repressed form with, by analogy with RIG-I, CARD(s) binding to hel that prevents direct access of any RNA to the hel domain. Upon encountering,
a viral dsRNA binds to MDA5 hel (2). CTD binds to RNA and hel2i and induces CARD release and exposure of the self-oligomerization domain. This
nucleates the binding of another MDA5 molecule on the same RNA (3) and so on so as to constitute a multivalent CARD signalling platform (4).
The binding of dsRNA to the hel also allosterically favours ATP binding to the ATPase motor (2). This drives fast ATP hydrolysis (5) with allosteric
release of the dsRNA from the hel domain of MDA5, disassembly of the oligomer into monomers that returns back to their auto-repressed state.
b A serendipitous binding to cellular (self) RNA (1b) can induce ATP binding (2b) but the self RNA is evicted before any recruitment of another
MDA5 can occur (that is, step 5 is prevalent over step 3). Consequently, there is no signal elicitation (4b). c Model of the constitutive activity of
ATPase-deficient MDA5. MDA5-E444Q serendipitously binds to surrounding cellular (self) RNA via its hel domain (step 1b, not shown, see panel b)
with binding of CTD to RNA and hel2i and exposure of both CARDs and oligomerization site. Because of the poor efficiency of its ATPase motor,
step 5 cannot occur, the illegitimate self RNA cannot be expelled from the hel domain and multiple MDA5 in active state assemble into a long-lived
multivalent platform (step 3) that keeps transducing the downstream signal (4c). Note that the multivalent platform may be made of MDA5 subunits
bound to different short stretches of self RNA. CARD: caspase activation and recruitment domain; CTD: C-terminal domain; hel: helicase
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bound to MDA5 hel (E444Q mutant, Fig. 7c step 2a).
Consequently, multiple activated MDA5 molecules ac-
cumulate so as to constitute a long-lived multivalent
platform that keeps transducing the downstream sig-
nal (Fig. 7c, step 3 and 4c). As discussed for RIG-I,
the hel domain of the homologous mutants K335A in
motif I and TS/AA in motif III are predicted to have
a reduced RNA binding ability. However, this lower
affinity for dsRNA appears still sufficient to engage
the nucleation of MDA5 oligomerization that could
not be counteracted because of the associated defi-
ciency in ATP binding and/or hydrolysis.
Conclusion
We propose that RIG-I and MDA5 use their ATPase
motors to kinetically avoid the formation of long-
enough lived signal transducing units resulting from the
binding of an illegitimate self RNA. In the case of RIG-I,
accurate recognition of 5′pppdsRNA is ensured by: (i)
strong binding to the CTD; (ii) cis-recognition of the
dsRNA moiety by hel locked by cooperative ATP bind-
ing; and (iii) reiteration of the cis-binding of the CTD-
anchored dsRNA to hel via multiple ATP hydrolysis
cycles to sustain enough numbers of activated RIG-I per
time unit. In the case of MDA5, the ATPase activity dis-
cards any RNA bound to MDA5 hel that does not have
a dsRNA structure long enough to allow a timely effi-
cient nucleation of MDA5 into an active oligomeric sig-
nalling platform. Interestingly, a potential source of
natural cellular (self ) dsRNA that RIG-I and/or MDA5
might need to discriminate against, has just been uncov-
ered [64]. Altogether, our work provides a framework to
understand at the molecular level the contribution of
several natural gain-of-function variants, including the
MDA5 ATPase-deficient R337G variant, and RIG-I
C268F and E373A that are associated with severe auto-
immune disorders, including interferonopathy and atyp-
ical Singleton-Merten syndrome [42–45] or enhanced
clearing of hepatitis C virus [41].Methods
Plasmids
The cDNA coding for wild-type and variants of human
Flag-tagged RIG-I and myc-tagged MDA5 were sub-
cloned into pEF-BOS expression vector and measles
virus V protein (Moraten strain) constructs in pCG vec-
tor using PCR amplification of cDNA fragments and the
InFusion (Clontech, Mountain View, CA, USA) recom-
binant technique [30]. MDA5 constructs were built on
the T946 variant (pEF-MDA5-c-myc plasmid [65]). This
variant shows genetic linkage with type I diabetes [66]
alone or in association with R843H [67]. It was later
claimed to be associated with both a constitutive activity
and a deficiency in ATP hydrolysis [43, 45]. However,
Additional file 5A shows that T946 and A946 variants
exhibited a similar activity profile in agreement with pre-
vious observations [65, 66]. Every RIG-I, MDA5 and
MeV V insert construct after subcloning in the expres-
sion vector was entirely verified by sequencing (Eurofins,
Ebersberg, Germany). All plasmids will be deposited in
the Addgene plasmid repository service.
Poly(I:C) and RNA
Poly(I:C) and Phi6 dsRNA was purchased from Amersham
Biosciences (Amersham, UK) and Thermo Scientific
(Waltham, MA, USA), respectively. Rabies leader 5′
ppp-RNA (GGACGCUUAACAACAAAACCAGAGAAG
AAAAAGACA-GCGUCAAUUGCAAACGAAAAAUG
UGC) was T7 transcribed and purified by excising
the band from a denaturing urea-PAGE [30]. The
61-mer-5′pppdsRNA was obtained by annealing two





CACGG). Both 61-mer-5′ppp-ssRNA contain only three
nucleotides to avoid the formation of secondary structure
and the production of double-stranded side products
RNA often generated by the T7 polymerase [68].
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To limit the risk of signals being overshadowed by those
possibly coming from endogenous or IFN-induced RIG-I
or MDA5, as previously quoted [27], the analysis of func-
tional phenotype of RIG-I and MDA5 proteins bearing ra-
tionally designed amino acid substitutions was performed
in the Huh7.5 cell line defective in MDA5 and IFN recep-
tor expression and expressing the inactive T55I RIG-I
[69–73], a phenotype verified experimentally in Additional
file 1. The phenotype of few key RIG-I and MDA5 con-
structs was also analyzed in 293T cells, which is equipped
with a low but functional endogenous RLR with normal
response to type I IFN (see Additional file 3).
The human IFNβ promoter luciferase assay was per-
formed essentially as described [18, 30]. Briefly, Huh7.5
cells were co-transfected with RIG-I or MDA5 expressing
vectors together with the reporter pb-IFN-luc followed
one day later by transfection of either poly(I:C) (Amersham
Biosciences), Phi6 dsRNA (Thermo Scientific) or 61-mer-5′
pppdsRNA [68]. Unless otherwise indicated, the data were
expressed as mean of normalized luciferase activity and SD
from three independent experiments, each done in inde-
pendent triplicates.
Immunoblot analysis
Immunoblotting was performed as detailed elsewhere
[18, 74]. Transfected cells were lysed in NP40 buffer
with 6M urea (20 mM Tris HCl pH 8, 150 mM NaCl,
0.6 % NP-40, 2 mM EDTA) for 20 minutes on ice. The
proteins were then separated from the cell debris by
centrifugation at 7,000 g during 10 minute. The proteins
were denatured by the addition of Laemmli 1 x loading
buffer before analysis by SDS-PAGE and immunoblot-
ting using anti-Flag (1:1,000; M2; Sigma, St. Louis, MO,
USA), anti-C-Myc (1:50) 9E10, anti-GAPDH (1:2,000;
Millipore, Billerica, MA, USA) monoclonal antibodies
and rabbit polyclonal anti-P/V antiserum (1:40,000 [75]).
Electrophoretic mobility shift assay (EMSA)
EMSA was performed to compare the binding affinity be-
tween wild-type protein and mutated protein of duck
RIG-I (dRIG-I) and chicken MDA5 (chMDA5). 12 bp and
24 bp palindromic duplex RNA (5′-pGGUAGCGC
UACC-3′) (12dsRNA) (5′-pGGGACGUCAUGCGCAUG
ACGUCCC-3′) (24dsRNA) was cy3 labeled using a Mirus
kit (Madison, WI, USA). The labeled dsRNA was dissolved
with the buffer (20 mM Hepes pH 6.8, 2mM EDTA). Re-
actions (5 μl) contained 1.8 μM labeled dsRNA and vary-
ing concentrations of protein. The reaction mixtures
were incubated for 10 minutes at room temperature in
EMSA buffer (20 mM Hepes pH 7.5, 150 mM NaCl, 2
mM MgCl2, 2 mM ATP, 5 % glycerol, 0.1 mg/ml
BSA). They were then loaded on a 2.5 % low melting
temperature agarose gel and run with 0.5 x TBE atroom temperature for 15 minutes. The gels were im-
aged by the fluorescent imager Typhoon Trio (Amer-
sham Biosciences).ATPase activity assays
ATP hydrolysis by dRIG-I and chMDA5 was measured by
the Malachite green assay (BioAssay Systems, Hayward,
CA, USA). Then 0.5 μM dRIG-I was preincubated with
four-fold excess of a 12-mer dsRNA or 8 μM chMDA5
was preincubated with four-fold excess of a 24-mer
dsRNA, for 10 minutes at 28° in ATP hydrolysis buffer (20
mM Hepes pH 7.5, 100 mM NaCl, 1 % glycerol, 2 mM
DTT, 4 mM MgCl2). The reaction was initiated by adding
2 mM ATP. Reaction aliquots of 10 μl were quenched at
time points between 15 seconds and 30 minutes by mixing
with 10 μl of quenching buffer (20 mM Hepes pH 7.5, 100
mM NaCl, 1 % glycerol, 2 mM DTT, 100 mM EDTA).
Then, 80 μl of five times diluted Malachite green reagent
was added and developed for 60 minutes at room
temperature. The absorbance at 622 nm was measured
with a plate reader (Infinite 200 PRO; Tecan, Maennedorf,
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